– because cancer patients are individuals

News and Press Releases

2019-11-06

News

2cureX continues its efforts to ensure a strong IP protection for its IndiTreat test in the United States

2cureX AB (“2cureX”, NASDAQ: 2CUREX) is pleased to announce that a patent on the IndiTreat® test has been granted in...

2019-10-15

Press releases regulatory

2cureX continues its IP expansion by securing a patent on Its IndiTreat test in Hong Kong

2cureX AB (“2cureX”, NASDAQ: 2CUREX) is pleased to announce the granting of a Hong Kong patent (HK1237870) on its key...

2019-10-08

Press releases regulatory

2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries

2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has established a commercial agreement with one of the largest...

To the news archive

Meet 2cureX

Maj 26, 2020

American Society of Clinical Oncology, ASCO, Chicago, US

Click here for more information

March 17, 2020

Oncology Convention 2020, Birmingham, UK

Click here for more information

February 19-22, 2020

German Cancer Congress, 34 Deutscher Krebs Kongress 2020, Berlin, Germany

Click here for more information

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint